VaramirStart free · no cardSign in
TRVI as of Nov 1 · 21:09 ET
TRVINasdaqPharmaceutical Preparations

Trevi Therapeutics, Inc. · Brief

Next report

10 days

Nov 12 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±12.7%
avg realized
±2.3%
Mar 18 '25±8.9%▲+3.81%×0.43
May 8 '25±13.2%0.00%×0.00
Aug 7 '25±9.3%▲+1.64%×0.18
Q3 FY25±18.0%▼−0.79%×0.04
Q1 FY26±11.9%▼−4.47%×0.38
Apr 17 '26±17.5%▲+4.75%×0.27
May 5 '26±8.2%▼−2.73%×0.33
Q2 FY26±14.8%▲+0.05%×0.00
quarterimplied−20%0+20%realized×
Q2 FY26±14.8%▲+0.05%×0.00
May '26±8.2%▼−2.73%×0.33
Apr '26±17.5%▲+4.75%×0.27
Q1 FY26±11.9%▼−4.47%×0.38
Q3 FY25±18.0%▼−0.79%×0.04
Aug '25±9.3%▲+1.64%×0.18
2 older reports
May '25±13.2%0.00%×0.00
Mar '25±8.9%▲+3.81%×0.43
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2

3disclosed supplier and customer ties in SEC filingsSEC filings
219managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history
3tracked funds holding TRVIN-PORT · Aug 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TRVI report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±16.2% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.